NRC Health APIC, Share-based Payment Arrangement, Increase for Cost Recognition
NRC Health (NRC) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $7.37 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-04
- NRC Health apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $7.37M, a 2300.98% increase year-over-year.
- NRC Health apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $1.61M, a 840.35% increase year-over-year.
- NRC Health apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $925.00K.
- NRC Health apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $307.00K.
- NRC Health apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $3.31M, a 1066.20% increase from fiscal 2024.
- NRC Health apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $284.00K, a 69.63% decline from fiscal 2023.
- NRC Health apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $935.00K, a 22.08% decline from fiscal 2022.
- NRC Health apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $1.20M, a 92.62% increase from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $7.37M 10-Q · filed 2026-08-04 | $8.98M derived: sum of 2 quarters · filed 2026-08-04 | ||
| 2026-03-31 | $1.61M 10-Q · filed 2026-08-04 | |||
| 2025-12-31 | $3.31M 10-K · filed 2026-03-05 | |||
| 2025-09-30 | $925.00K 10-Q · filed 2025-11-07 | $1.23M derived: sum of 2 quarters · filed 2026-08-04 | $1.40M derived: sum of 3 quarters · filed 2026-08-04 | |
| 2025-06-30 | $307.00K 10-Q · filed 2026-08-04 | $478.00K derived: sum of 2 quarters · filed 2026-08-04 | ||
| 2025-03-31 | $171.00K 10-Q · filed 2026-08-04 | |||
| 2024-12-31 | $284.00K 10-K · filed 2026-03-05 | |||
| 2024-03-31 | $36.00K 10-Q · filed 2024-05-09 | |||
| 2023-12-31 | $935.00K 10-K · filed 2026-03-05 | |||
| 2023-09-30 | $68.00K 10-Q · filed 2023-11-09 | $373.00K derived: sum of 2 quarters · filed 2023-11-09 | $677.00K derived: sum of 3 quarters · filed 2024-05-09 | |
| 2023-06-30 | $305.00K 10-Q · filed 2023-11-09 | $609.00K derived: sum of 2 quarters · filed 2024-05-09 | ||
| 2023-03-31 | $304.00K 10-Q · filed 2024-05-09 | |||
| 2022-12-31 | $1.20M 10-K · filed 2025-03-17 | |||
| 2022-09-30 | $291.00K 10-Q · filed 2023-11-09 | $625.00K derived: sum of 2 quarters · filed 2023-11-09 | $910.00K derived: sum of 3 quarters · filed 2023-11-09 | |
| 2022-06-30 | $334.00K 10-Q · filed 2023-11-09 | $619.00K derived: sum of 2 quarters · filed 2023-11-09 | ||
| 2022-03-31 | $285.00K 10-Q · filed 2023-11-09 | |||
| 2021-12-31 | $623.00K 10-K · filed 2024-02-27 | |||
| 2020-12-31 | $680.00K 10-K · filed 2023-03-03 | |||
| 2020-09-30 | $274.00K 10-Q · filed 2020-11-06 | $415.00K derived: sum of 2 quarters · filed 2020-11-06 | $747.00K derived: sum of 3 quarters · filed 2020-11-06 | |
| 2020-06-30 | $141.00K 10-Q · filed 2020-11-06 | $473.00K derived: sum of 2 quarters · filed 2020-11-06 | ||
| 2020-03-31 | $332.00K 10-Q · filed 2020-11-06 | |||
| 2019-12-31 | $1.22M 10-K · filed 2021-03-05 | |||
| 2019-09-30 | $308.00K 10-Q · filed 2020-11-06 | $615.00K derived: sum of 2 quarters · filed 2020-11-06 | $917.00K derived: sum of 3 quarters · filed 2020-11-06 | $1.18M derived: sum of 4 quarters · filed 2021-03-05 |
| 2019-06-30 | $307.00K 10-Q · filed 2020-11-06 | $609.00K derived: sum of 2 quarters · filed 2020-11-06 | $868.00K derived: sum of 3 quarters · filed 2021-03-05 | $1.13M derived: sum of 4 quarters · filed 2021-03-05 |
| 2019-03-31 | $302.00K 10-Q · filed 2020-11-06 | $561.00K derived: sum of 2 quarters · filed 2021-03-05 | $821.00K derived: sum of 3 quarters · filed 2021-03-05 | $1.36M derived: sum of 4 quarters · filed 2021-03-05 |
| 2018-12-31 | $259.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-05 | $519.00K derived: sum of 2 quarters · filed 2021-03-05 | $1.06M derived: sum of 3 quarters · filed 2021-03-05 | $1.51M 10-K · filed 2021-03-05 |
| 2018-09-30 | $260.00K 10-Q · filed 2019-11-08 | $801.00K derived: sum of 2 quarters · filed 2019-11-08 | $1.25M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $541.00K 10-Q · filed 2019-11-08 | $995.00K 10-Q · filed 2018-08-09 | ||
| 2018-03-31 | $454.00K 10-Q · filed 2019-11-08 | |||
| 2017-12-31 | $1.84M 10-K · filed 2020-03-06 | |||
| 2016-12-31 | $1.93M 10-K · filed 2019-03-08 | |||
| 2015-12-31 | $1.38M 10-K · filed 2018-03-14 | |||
| 2014-12-31 | $742.00K 10-K · filed 2017-03-03 | |||
| 2013-12-31 | $955.00K 10-K · filed 2016-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |